Latest filing published 20 May 2024 for ATAI Life Sciences N.V., €267k. Read the official filing
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Florian Brand appears in our data through filings on ATAI Life Sciences N.V. shares, published by SEC (Form 4). Over a trading history stretching from 22 June 2021 to 16 May 2024, the count stands at 6 filings.
Market trades split into 4 purchases (€200k) and 1 sale (€267k). Netting one side against the other leaves €67k of net selling. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 1 option exercise. Since January 2024: no purchases and 1 sale on the market.
Half of the purchases are above €42k and half below. Of 4 purchases, 2 formed part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster.
On 20 May 2024 came the latest disclosure, an open-market sale for €267k in ATAI Life Sciences N.V. The clock since the last published purchase (20 November 2023) now reads 1,063 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations